Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme
Abstract Novel series of 5-benzylidenethiazolidine-2, 4-dione derivatives 4 ac-8 af were
designed, synthesized and evaluated for anticancer activity against HepG2, HCT-116 and …
designed, synthesized and evaluated for anticancer activity against HepG2, HCT-116 and …
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme
K El-Adl, AGA El-Helby, H Sakr… - Bioorganic …, 2020 - pubmed.ncbi.nlm.nih.gov
Novel series of 5-benzylidenethiazolidine-2, 4-dione derivatives 4 ac-8 af were designed,
synthesized and evaluated for anticancer activity against HepG2, HCT-116 and MCF-7 cell …
synthesized and evaluated for anticancer activity against HepG2, HCT-116 and MCF-7 cell …
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme.
K El-Adl, AA El-Helby, H Sakr, IH Eissa… - Bioorganic …, 2020 - europepmc.org
Novel series of 5-benzylidenethiazolidine-2, 4-dione derivatives 4 ac-8 af were designed,
synthesized and evaluated for anticancer activity against HepG2, HCT-116 and MCF-7 cell …
synthesized and evaluated for anticancer activity against HepG2, HCT-116 and MCF-7 cell …